Insights from 2023 ESMO Annual Meeting
ESMO 2023 Insights: "The BonEnza Study - Changes in Bone Mineral Density, Trabecular Bone Score, and Body Composition in mHSPC Patients Randomized to Receive ADT+Enzalutamide+/-Zoledronic Acid"
Comments 0
Login to view comments.
Click here to Login
